Cargando…
Expression of NEAT1 can be used as a predictor for Dex resistance in multiple myeloma patients
OBJECTIVE: Multiple myeloma is a heterogeneous disorder and the intratumor genetic heterogeneity contributes to emergency of drug resistance. Dexamethasone has been used clinically for decades for MM. Nevertheless, their use is severely hampered by the risk of developing side effects and the occurre...
Autores principales: | Ren, Yuyue, Liu, Yijun, He, Wanting, Zhao, Weiwei, Pan, Jiaqi, Gao, Haiyan, Li, Yuying, Zhang, Ying, Wang, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10320976/ https://www.ncbi.nlm.nih.gov/pubmed/37407915 http://dx.doi.org/10.1186/s12885-023-11084-x |
Ejemplares similares
-
P38 PATIENT-REPORTED OUTCOMES (PRO) IN RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) TREATED WITH MELFLUFEN AND DEXAMETHASONE (DEX) OR POMALIDOMIDE (POM) AND DEX: ANALYSES FROM THE PHASE 3 OCEAN STUDY
por: Schjesvold, F, et al.
Publicado: (2023) -
DEX, Delirium and Dilemma
por: Magoon, Rohan, et al.
Publicado: (2023) -
Synergistic Effect of Perineural Dexamethasone and Dexmedetomidine (Dex-Dex) Prolong Analgesic Effect of a Preoperative Interscalene Block
por: Noor, Nazir A, et al.
Publicado: (2020) -
Coadministration of Stigmasterol and Dexamethasone (STIG+DEX) Modulates Steroid-Resistant Asthma
por: Hohoayi, Abigail, et al.
Publicado: (2022) -
Effects of Voltage-Gated K(+) Channel on Cell Proliferation in Multiple Myeloma
por: Wang, Wei, et al.
Publicado: (2014)